These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2322995

  • 1. Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.
    Tsuda H, Takahashi S, Yamaguchi S, Ozaki K, Ito N.
    Carcinogenesis; 1990 Apr; 11(4):549-52. PubMed ID: 2322995
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
    Ito N, Hasegawa R, Shirai T, Fukushima S, Hakoi K, Takaba K, Iwasaki S, Wakabayashi K, Nagao M, Sugimura T.
    Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Demonstration of initiation potential of carcinogens by induction of preneoplastic glutathione S-transferase P-form-positive liver cell foci: possible in vivo assay system for environmental carcinogens.
    Tsuda H, Matsumoto K, Ogino H, Ito M, Hirono I, Nagao M, Sato K, Cabral R, Bartsch H.
    Jpn J Cancer Res; 1993 Mar; 84(3):230-6. PubMed ID: 7683635
    [Abstract] [Full Text] [Related]

  • 6. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
    Fukushima S, Wanibuchi H, Morimura K, Wei M, Nakae D, Konishi Y, Tsuda H, Takasuka N, Imaida K, Shirai T, Tatematsu M, Tsukamoto T, Hirose M, Furukawa F.
    Cancer Lett; 2003 Feb 28; 191(1):35-40. PubMed ID: 12609707
    [Abstract] [Full Text] [Related]

  • 7. Enhancement by cigarette smoke exposure of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis in close association with elevation of hepatic CYP1A2.
    Nishikawa A, Furukawa F, Miyauchi M, Son HY, Okazaki K, Koide A, Mori Y, Hirose M.
    Jpn J Cancer Res; 2002 Jan 28; 93(1):24-31. PubMed ID: 11802804
    [Abstract] [Full Text] [Related]

  • 8. Heterocyclic amine mixture carcinogenesis and its enhancement by caffeine in F344 rats.
    Tsuda H, Sekine K, Uehara N, Takasuka N, Moore MA, Konno Y, Nakashita K, Degawa M.
    Cancer Lett; 1999 Sep 01; 143(2):229-34. PubMed ID: 10503909
    [Abstract] [Full Text] [Related]

  • 9. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
    Kawabe M, Futakuchi M, Tamano S, Shirai T, Hirose M.
    Food Chem Toxicol; 2008 Aug 01; 46(8):2758-63. PubMed ID: 18547703
    [Abstract] [Full Text] [Related]

  • 10. Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse.
    Dooley KL, Von Tungeln LS, Bucci T, Fu PP, Kadlubar FF.
    Cancer Lett; 1992 Mar 15; 62(3):205-9. PubMed ID: 1596864
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of nongenotoxic and genotoxic carcinogens on the preneoplastic lesions in the rat liver.
    Kim DJ, Lee KK, Hong JT.
    Arch Pharm Res; 1998 Aug 15; 21(4):363-9. PubMed ID: 9875460
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The heterocyclic amines IQ and MeIQx show no promotive effect in a short-term in vivo liver carcinogenesis assay.
    Kleman MI, Overvik E, Porsch-Hällström I, Blanck A, Gustafsson JA.
    Carcinogenesis; 1993 Oct 15; 14(10):2123-5. PubMed ID: 8222065
    [Abstract] [Full Text] [Related]

  • 14. Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion.
    Tsuda H, Asamoto M, Ogiso T, Inoue T, Ito N, Nagao M.
    Jpn J Cancer Res; 1988 Jun 15; 79(6):691-7. PubMed ID: 3137195
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen.
    Kassie F, Uhl M, Rabot S, Grasl-Kraupp B, Verkerk R, Kundi M, Chabicovsky M, Schulte-Hermann R, Knasmüller S.
    Carcinogenesis; 2003 Feb 15; 24(2):255-61. PubMed ID: 12584175
    [Abstract] [Full Text] [Related]

  • 17. Genetic alterations in HCA-induced tumors.
    Ushijima T, Makino H, Kakiuchi H, Inoue R, Sugimura T, Nagao M.
    Princess Takamatsu Symp; 1995 Feb 15; 23():281-91. PubMed ID: 8844820
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of hepatocarcinogenesis by combined administration of food-derived heterocyclic amines at low doses in the rat.
    Hasegawa R, Kato T, Hirose M, Takahashi S, Shirai T, Ito N.
    Food Chem Toxicol; 1996 Feb 15; 34(11-12):1097-101. PubMed ID: 9119321
    [Abstract] [Full Text] [Related]

  • 19. Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: relevance to risk assessment.
    Fukushima S.
    Cancer Lett; 1999 Sep 01; 143(2):157-9. PubMed ID: 10503896
    [Abstract] [Full Text] [Related]

  • 20. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats.
    Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, Kono T, Nishibe S, Shirai T.
    Cancer Lett; 2000 Jul 03; 155(1):79-88. PubMed ID: 10814883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.